Cerebral Small Vessel Disease and Cognitive Impairment in Aging Brain

A special issue of Brain Sciences (ISSN 2076-3425).

Deadline for manuscript submissions: closed (15 June 2020) | Viewed by 224

Special Issue Editor


E-Mail Website
Guest Editor
1. Saw Swee Hock School of Public Health, National University of Singapore, Singapore
2. National University of Singapore, Memory Aging and Cognition Centre, Department of Pharmacology, Singapore
Interests: cerebral small vessel disease; dementia; cognition; neuroimaging; cardiovascular disease

Special Issue Information

Dear Colleagues,

Cerebral small vessel disease (SVD) is considered a major cause and contributor to cognitive decline and dementia. SVD represents a wide range of pathological processes affecting arteries, arterioles, venules, and capillaries, resulting in ischemic, hemorrhagic, and inflammatory damage. The magnetic resonance imaging markers of SVD include white matter hyperintensities, lacunes, cerebral microbleeds, cerebral microinfarcts, and enlarged perivascular spaces. SVD is reported to be one of the leading causes of cognitive impairment, dementia, stroke, and physical disability. SVD is a potentially treatable condition by targeting vascular risk factors. Investigating and addressing the impact of SVD on cognition as well as its interactive effects on neurodegeneration is paramount to understanding how to mitigate the effects of vascular disease on the aging brain (molecular to behavioral mechanisms).

This Special Issue invites articles from both basic sciences to applied scientific approaches that aim to fill this gap by elucidating the role of SVD as the missing link in the interactive effects of vascular and neurodegenerative pathologies in the brain. These contributions will provide crucial insights to the scientific community in order to develop preventive and therapeutic interventions which are pertinent for prioritizing public health efforts to tackle this devastating illness.

Prof. Saima Hilal
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Cerebral small vessel disease
  • Alzheimer’s disease
  • Cognitive impairment
  • Neuroimaging
  • Vascular biomarkers

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop